HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Katsumi Doh-ura Selected Research

chrysoidine

5/2007Chelating compound, chrysoidine, is more effective in both antiprion activity and brain endothelial permeability than quinacrine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Katsumi Doh-ura Research Topics

Disease

17Prion Diseases (Transmissible Spongiform Encephalopathies)
01/2013 - 03/2002
4Neuroblastoma
04/2014 - 05/2007
4Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
01/2013 - 05/2005
3Alzheimer Disease (Alzheimer's Disease)
01/2013 - 03/2002
3Amyloid Plaque
01/2013 - 12/2003
2Neoplasms (Cancer)
02/2011 - 09/2002
2Amyloidosis
05/2010 - 12/2003
2Scrapie
07/2008 - 05/2006
2Disease Progression
05/2005 - 03/2002
1Sporadic Creutzfeldt-Jakob Disease
05/2010
1Disease Susceptibility (Diathesis)
11/2009
1Bovine Spongiform Encephalopathy (Mad Cow Disease)
08/2009
1Neurodegenerative Diseases (Neurodegenerative Disease)
08/2007
1Coinfection
04/2007
1Acquired CJD
05/2005
1Muscular Diseases (Myopathy)
07/2004
1Immunoglobulin Light-chain Amyloidosis
12/2003
1Amyloid Neuropathies (Amyloid Neuropathy)
12/2003
1Polyneuropathies (Polyneuropathy)
12/2003
1Schizophrenia (Dementia Praecox)
07/2003
1Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
05/2003
1Glioma (Gliomas)
09/2002
1Dementia (Dementias)
09/2002
1Parkinson Disease (Parkinson's Disease)
09/2002
1Multiple System Atrophy
09/2002
1Synucleinopathies
09/2002

Drug/Important Bio-Agent (IBA)

14Prion ProteinsIBA
04/2014 - 07/2003
10PrionsIBA
04/2014 - 05/2006
4Proteins (Proteins, Gene)FDA Link
02/2011 - 03/2002
3Amyloid (Amyloid Fibrils)IBA
01/2013 - 12/2003
3Pharmaceutical PreparationsIBA
11/2009 - 05/2004
3Quinacrine (Mepacrine)IBA
07/2008 - 11/2004
3ClusterinIBA
07/2004 - 03/2002
22- (2- (2- dimethylaminothiazol- 5- yl)ethenyl)- 6- (2- (fluoro)ethoxy)benzoxazoleIBA
01/2013 - 05/2010
2Peptide Hydrolases (Proteases)FDA Link
03/2010 - 05/2004
2Pentosan Sulfuric Polyester (Pentosan Polysulfate)FDA Link
11/2009 - 11/2004
2Codon (Codons)IBA
11/2007 - 05/2005
2Cathepsin BIBA
07/2004 - 05/2003
1phenylhydrazine (phenylhydrazine hydrochloride)IBA
01/2013
1Biological ProductsIBA
02/2011
1polysaccharide-KIBA
02/2011
1gamma-Aminobutyric Acid (GABA)IBA
03/2010
1Doxycycline (Periostat)FDA LinkGeneric
11/2009
1Biomarkers (Surrogate Marker)IBA
08/2009
1AutoantibodiesIBA
08/2009
1Glial Fibrillary Acidic ProteinIBA
08/2009
1J 113397IBA
02/2009
1Arginine (L-Arginine)FDA Link
11/2007
1Methionine (L-Methionine)FDA Link
11/2007
1chrysoidineIBA
05/2007
1Coloring Agents (Dyes)IBA
05/2006
1Quinine (Quinson)FDA Link
11/2004
1Antimalarials (Antimalarial Agents)IBA
11/2004
1Heparitin Sulfate (Heparan Sulfate)IBA
07/2004
1ClathrinIBA
07/2004
1Chloroquine (Aralen)FDA LinkGeneric
07/2004
1Protein Isoforms (Isoforms)IBA
05/2004
1Endopeptidase K (Proteinase K)IBA
05/2004
1PrPSc ProteinsIBA
05/2004
1Prealbumin (Transthyretin)IBA
12/2003
1QuartzIBA
12/2003
1AA amyloidosisIBA
12/2003
1Heparin (Liquaemin)FDA LinkGeneric
09/2002
1Membrane Proteins (Integral Membrane Proteins)IBA
09/2002
1AntigensIBA
09/2002
1Epidermal Growth Factor (EGF)IBA
09/2002

Therapy/Procedure

8Therapeutics
01/2013 - 11/2003
1Drug Therapy (Chemotherapy)
12/2007
1Blood Transfusion (Blood Transfusions)
04/2007